Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Can Help On Drug Prices – Except When It Can't, Califf Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Commissioner nominee tells Senate that faster approvals of cheap products and quicker development of innovative ones will reduce pricing pressure; 'monopoly' positions are a concern, but Califf draws the line when asked about drug importation.


Related Content

Democrats’ Drug Pricing Bills Echo Trump Ideas But Broad Republican Support Unlikely
Drug Importation Can Be Triggered By 'Excessive' Price Increases; Now US FDA Has To Decide What That Means
FDA Confirmation Watch: Gottlieb Likely To Face Questions About Approval Standards, Ties To Industry
US FDA Commissioner Confirmation: Gottlieb To Get Questions On Approval Standards, Ties To Industry
Califf Supports Combo Products Pathway At Confirmation Hearing


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts